Review
Published on 16 Jul 2024
Progress of natural sesquiterpenoids in the treatment of hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1445222
- 1,219 views
Type at least 3 characters
1,008 articles
Articles
Brief Research Report
Published on 15 Jul 2024
Withametelin inhibits TGF-β induced Epithelial-to-Mesenchymal Transition and Programmed-Death Ligand-1 expression in vitro
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1435516
- 801 views
Original Research
Published on 12 Jul 2024
Risk factors of osimertinib-related cardiotoxicity in non-small cell lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1431023
- 970 views
Editorial
Published on 08 Jul 2024
Editorial: Precision therapy and biomarkers in head and neck squamous cell carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1442630
- 590 views
Original Research
Published on 04 Jul 2024
Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naïve patients with PSA 4~20 ng/ml
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1413953
- 833 views
Original Research
Published on 01 Jul 2024
Identification of a basement membrane-related gene signature for predicting prognosis, immune infiltration, and drug sensitivity in colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1428176
- 1,213 views
- 1 citation
Mini Review
Published on 24 Jun 2024
EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1426796
- 1,241 views
Perspective
Published on 21 Jun 2024
Elemental biomapping of human tissues suggests toxic metals such as mercury play a role in the pathogenesis of cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1420451
- 1,138 views
Review
Published on 18 Jun 2024
Integrating Chinese medicine into mainstream cancer therapies: a promising future
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1412370
- 1,561 views
Original Research
Published on 17 Jun 2024
Combined aqupla, paclitaxel liposome, and docetaxel treatment: survival and biomarker outcomes in recurrent ovarian cancer patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1422117
- 675 views
Original Research
Published on 13 Jun 2024
Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1272432
- 760 views
Correction
Published on 03 Jun 2024
Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1412472
- 622 views
Methods
Published on 31 May 2024
ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1343091
- 976 views
Original Research
Published on 08 May 2024
The application of Global Trigger Tool in monitoring antineoplastic adverse drug events: a retrospective study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1230514
- 738 views
Original Research
Published on 01 May 2024
Electrochemical DNA-nano biosensor for the detection of Goserelin as anticancer drug using modified pencil graphite electrode
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1321557
- 2,736 views
Original Research
Published on 30 Apr 2024
In silico evaluation of anti-colorectal cancer inhibitors by Resveratrol derivatives targeting Armadillo repeats domain of APC: molecular docking and molecular dynamics simulation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2024.1360745
- 2,183 views
- 1 citation